Emerging and Established Models of Bone Metastasis

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2018 Jun 6

PMID 29865211

Citations 19

Authors

Alexander H Jinnah

Benjamin C Zacks

Chukwuweike U Gwam

Bethany A Kerr

Affiliations

Soon will be listed here.

Abstract

Metastasis is the leading cause of cancer-related death and drives patient morbidity as well as healthcare costs. Bone is the primary site of metastasis for several cancers-breast and prostate cancers in particular. Efforts to treat bone metastases have been stymied by a lack of models to study the progression, cellular players, and signaling pathways driving bone metastasis. In this review, we examine newly described and classic models of bone metastasis. Through the use of current in vivo, microfluidic, and in silico computational bone metastasis models we may eventually understand how cells escape the primary tumor and how these circulating tumor cells then home to and colonize the bone marrow. Further, future models may uncover how cells enter and then escape dormancy to develop into overt metastases. Recreating the metastatic process will lead to the discovery of therapeutic targets for disrupting and treating bone metastasis.

Citing Articles

Osteoarthritis as a Systemic Disease Promoted Prostate Cancer In Vivo and In Vitro.

Rosas S, Kwok A, Moore J, Shi L, Smith T, Tallant E Int J Mol Sci. 2024; 25(11).

PMID: 38892202 PMC: 11172560. DOI: 10.3390/ijms25116014.

Three-dimensional in vitro model of bone metastases of neuroblastoma as a tool for pharmacological evaluations.

Aveic S, Seidelmann M, Davtalab R, Corallo D, Vogt M, Rutten S Nanotheranostics. 2024; 8(1):1-11.

PMID: 38164505 PMC: 10750120. DOI: 10.7150/ntno.85439.

Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022.

Kung C, Skiba M, Crosby E, Gorzelitz J, Kennedy M, Kerr B J Natl Cancer Inst Monogr. 2023; 2023(61):149-157.

PMID: 37139978 PMC: 10157760. DOI: 10.1093/jncimonographs/lgad005.

Macrophages promote anti-androgen resistance in prostate cancer bone disease.

Li X, Selli C, Zhou H, Cao J, Wu S, Ma R J Exp Med. 2023; 220(4).

PMID: 36749798 PMC: 9948761. DOI: 10.1084/jem.20221007.

Modeling cancer immunoediting in tumor microenvironment with system characterization through the ising-model Hamiltonian.

Rojas-Dominguez A, Arroyo-Duarte R, Rincon-Vieyra F, Alvarado-Mentado M BMC Bioinformatics. 2022; 23(1):200.

PMID: 35637445 PMC: 9150349. DOI: 10.1186/s12859-022-04731-w.

References

Carvalho M, Reis R, Oliveira J . Mimicking the 3D biology of osteochondral tissue with microfluidic-based solutions: breakthroughs towards boosting drug testing and discovery. Drug Discov Today. 2018; 23(3):711-718. DOI: 10.1016/j.drudis.2018.01.008. View

Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D . Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer. 2004; 101(6):1345-56. DOI: 10.1002/cncr.20518. View

Garzon-Alvarado D . A mathematical model for describing the metastasis of cancer in bone tissue. Comput Methods Biomech Biomed Engin. 2011; 15(4):333-46. DOI: 10.1080/10255842.2010.535522. View

Wu X, Gong S, Roy-Burman P, Lee P, Culig Z . Current mouse and cell models in prostate cancer research. Endocr Relat Cancer. 2013; 20(4):R155-70. PMC: 3855867. DOI: 10.1530/ERC-12-0285. View

Ghajar C, Peinado H, Mori H, Matei I, Evason K, Brazier H . The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013; 15(7):807-17. PMC: 3826912. DOI: 10.1038/ncb2767. View

Bendre M, Margulies A, Walser B, Akel N, Bhattacharrya S, Skinner R . Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res. 2005; 65(23):11001-9. DOI: 10.1158/0008-5472.CAN-05-2630. View

Akech J, Wixted J, Bedard K, van der Deen M, Hussain S, Guise T . Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene. 2009; 29(6):811-21. PMC: 2820596. DOI: 10.1038/onc.2009.389. View

Singh A, Figg W . In vivo models of prostate cancer metastasis to bone. J Urol. 2005; 174(3):820-6. DOI: 10.1097/01.ju.0000169133.82167.aa. View

Newton P, Mason J, Venkatappa N, Jochelson M, Hurt B, Nieva J . Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites. NPJ Breast Cancer. 2017; 1:15018. PMC: 5515198. DOI: 10.1038/npjbcancer.2015.18. View

10.

Henriksen G, Breistol K, Bruland O, Fodstad O, Larsen R . Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Cancer Res. 2002; 62(11):3120-5. View

11.

Neveu B, Jain P, Tetu B, Wu L, Fradet Y, Pouliot F . A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer. Oncotarget. 2015; 7(2):1300-10. PMC: 4811461. DOI: 10.18632/oncotarget.6360. View

12.

Marlow R, Honeth G, Lombardi S, Cariati M, Hessey S, Pipili A . A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res. 2013; 73(23):6886-99. DOI: 10.1158/0008-5472.CAN-13-0991. View

13.

Mak I, Evaniew N, Ghert M . Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014; 6(2):114-8. PMC: 3902221. View

14.

Zhou X, Liu J . A computational model to predict bone metastasis in breast cancer by integrating the dysregulated pathways. BMC Cancer. 2014; 14:618. PMC: 4161863. DOI: 10.1186/1471-2407-14-618. View

15.

Wang H, Yu C, Gao X, Welte T, Muscarella A, Tian L . The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell. 2015; 27(2):193-210. PMC: 4326554. DOI: 10.1016/j.ccell.2014.11.017. View

16.

Thibaudeau L, Taubenberger A, Holzapfel B, Quent V, Fuehrmann T, Hesami P . A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone. Dis Model Mech. 2014; 7(2):299-309. PMC: 3917251. DOI: 10.1242/dmm.014076. View

17.

Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K . Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res. 2001; 61(5):2177-82. View

18.

Xia T, Wang G, Ding Q, Liu X, Zhou W, Zhang Y . Bone metastasis in a novel breast cancer mouse model containing human breast and human bone. Breast Cancer Res Treat. 2011; 132(2):471-86. DOI: 10.1007/s10549-011-1496-0. View

19.

Rosol T, Tannehill-Gregg S, LeRoy B, Mandl S, Contag C . Animal models of bone metastasis. Cancer. 2003; 97(3 Suppl):748-57. DOI: 10.1002/cncr.11150. View

20.

Kingsley L, Fournier P, Chirgwin J, Guise T . Molecular biology of bone metastasis. Mol Cancer Ther. 2007; 6(10):2609-17. DOI: 10.1158/1535-7163.MCT-07-0234. View